Concentrix (NASDAQ:CNXC – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $2.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.93 by $0.02, Briefing.com reports. The firm had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a return on equity of 16.02% and a net margin of 3.25%.The company’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.26 EPS. Concentrix updated its Q1 2026 guidance to 2.570-2.690 EPS and its FY 2026 guidance to 11.480-12.070 EPS.
Concentrix Trading Down 13.8%
Shares of NASDAQ CNXC opened at $37.97 on Tuesday. Concentrix has a 52-week low of $31.63 and a 52-week high of $66.00. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $2.36 billion, a P/E ratio of 8.56, a PEG ratio of 0.59 and a beta of 0.48. The stock’s 50 day moving average price is $38.43 and its two-hundred day moving average price is $46.77.
Insider Activity
In other news, CEO Christopher A. Caldwell acquired 2,000 shares of the company’s stock in a transaction dated Thursday, October 30th. The shares were bought at an average price of $42.03 per share, with a total value of $84,060.00. Following the purchase, the chief executive officer owned 286,661 shares of the company’s stock, valued at approximately $12,048,361.83. This represents a 0.70% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 3.20% of the company’s stock.
Institutional Inflows and Outflows
Concentrix News Roundup
Here are the key news stories impacting Concentrix this week:
- Positive Sentiment: Barrington Research reaffirmed an “outperform” rating and set a $62.00 price target, signaling analyst conviction that shares have upside from current levels. Read More.
- Neutral Sentiment: Concentrix reported fiscal Q4 and full-year 2025 results; the release is driving today’s market action as investors parse revenue, margins and management commentary for forward guidance. Read More.
- Neutral Sentiment: Pre-earnings previews and valuation looks have been published, giving investors context on expectations and multiples ahead of the print; these pieces discuss whether recent share moves and valuation are warranted. Read More.
- Neutral Sentiment: Coverage pieces and earnings previews outline key items to watch (revenue growth, margin trends, contract mix and guidance), which can amplify volatility as the market digests results. Read More.
- Neutral Sentiment: Reported short-interest data in the feed is anomalous (shows zero shares), so it does not appear to be a meaningful driver of today’s move based on the available figures.
- Negative Sentiment: Analysts and articles flag concern that while Concentrix has previously beaten guidance, expected revenue growth is slowing — investors often punish stocks when earnings beats are accompanied by weaker growth outlooks. Read More.
- Negative Sentiment: Commentary questioning whether current pricing reflects Concentrix’s multi‑year share decline and changing fundamentals may reinforce selling pressure until there’s clearer guidance or an earnings rebound. Read More.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the company. Weiss Ratings raised Concentrix from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday. Barrington Research reissued an “outperform” rating and issued a $62.00 price target on shares of Concentrix in a research note on Monday. Robert W. Baird decreased their target price on shares of Concentrix from $75.00 to $62.00 and set an “outperform” rating on the stock in a research report on Monday, September 29th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 price target on shares of Concentrix in a research note on Tuesday, September 23rd. Finally, Wall Street Zen raised shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, October 25th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Concentrix presently has a consensus rating of “Moderate Buy” and an average target price of $66.25.
Read Our Latest Stock Report on Concentrix
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Read More
- Five stocks we like better than Concentrix
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
